Press Releases
Search
-
07 Oct 2013
Successful placement of Inaugural €300-Million Issue of 7-Year Bonds
Marcy l'Etoile, France, October 7, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, announced the placement to institutional investors of its first issue of seven-year euro-bond...
-
30 Sep 2013
bioMérieux lance VIDAS® 25 OH Vitamine D TOTAL, un nouveau test pour le dosage de la vitamine D
Marcy l'Étoile, France, September 30, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of VIDAS® 25 OH Vitamin D Total for the measurement of total vita...
-
03 Sep 2013
First-Half 2013 Results
Sales: €754 million, with a marked acceleration in the second quarter (+ 4%*) Operating income before non-recurring items in line with objectives: €125 million, or 16.6% of sales Major investments in ...
-
03 Sep 2013
bioMérieux makes a significant acquisition in molecular biology in the U.S.
With the acquisition of BioFire, bioMérieux consolidates its position as a major player in infectious disease diagnostics With a complete range of technologies for clinical microbiology diagnostics, b...
-
22 Aug 2013
bioMérieux Announces U.S. FDA Clearance for VITEK® MS, a Revolutionary Technology which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics
Marcy L’Etoile (France) and Durham, NC - August 21, 2013 - bioMérieux today announced that it has been granted U.S. FDA 510(k) de novo clearance for VITEK® MS, the first clinical mass spectrometry MAL...
-
18 Jul 2013
First-Half 2013 Business Review
Sharp acceleration in organic growth in the second quarter, up 4% Double-digit growth in emerging markets up 14% Sustained gains in North America Industrial application sales up 11% 2013 organic sales...
-
27 Jun 2013
International Experts Join Forces against Superbugs at the 4th World Forum on Healthcare-Associated Infections and Antimicrobial Resistance
bioMérieux commits to supporting expert-defined global priorities...
-
20 Jun 2013
bioMérieux receives CE marking for VIDAS® 3, the new generation of VIDAS®
Marcy l'Étoile, France, June 20, 2013 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, has been granted CE marking. This instru...
-
30 May 2013
bioMérieux Receives FDA Approval for THxIDTM-BRAF Companion Diagnostic Test
The only CE-marked and FDA-approved BRAF test able to simultaneously detect 2 BRAF mutations, V600E and V600K providing high medical value information to select treatment for metastatic melanoma patie...
-
21 May 2013
Nicolas Cartier appointed Corporate Vice President, Industrial Microbiology Unit of bioMérieux
Marcy l’Etoile, France, May 21, 2013 — A major player in the field of in vitro diagnostics and world leader in industrial microbiology, bioMérieux has announced the appointment of Nicolas Cartier as C...
-
23 Apr 2013
bioMérieux - First-Quarter 2013 Business Review
Stable sales in a persistently difficult European economy 2013 objective of 3-5% organic sales growth maintained Solid commercial negotiations underway Confirmed favorable growth prospects in emerging...
-
25 Mar 2013
Veolia Environnement and bioMérieux initiate a research partnership to develop an innovative monitoring system for drinking water quality
Paris, Lyon, March 25, 2013 – At BIOVISION, the world life sciences forum, Veolia Environnement, global leader in water services and expert in environmental services, and bioMérieux, global player in ...
-
13 Mar 2013
biomerieux-2012-financial-results
2012 performance: objectives met Sales up 6.8% at constant exchange rates €260 million in operating income before non-recurring items €134 million in free cash flow Robust international expansion, par...
-
23 Jan 2013
2012 Business Review & Investor Day
2012 Business Review Sales up 6.8% at constant exchange rates, in line with targets for the year Investor Day Innovation and commercial strategy to drive competitiveness...
-
04 Dec 2012
bioMérieux Opens a Subsidiary in Vietnam, Strengthening its Footprint in High-growth Southeast Asia
Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, announces the opening of its 41st commercial subsidiary in Hanoi, Vietnam. This wholly owned company in Vietna...